Comparative Pharmacology
Head-to-head clinical analysis: DISPERMOX versus V CILLIN K.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DISPERMOX versus V CILLIN K.
DISPERMOX vs V-CILLIN K
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Amoxicillin inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), inhibiting transpeptidase activity and disrupting peptidoglycan cross-linking.
Penicillin V exerts bactericidal activity by inhibiting bacterial cell wall synthesis through binding to penicillin-binding proteins (PBPs), inhibiting transpeptidase activity, and disrupting peptidoglycan cross-linking.
Adults: 1 g (as amoxicillin 875 mg + clavulanate 125 mg) orally every 12 hours for 7-10 days.
250-500 mg orally every 6 hours for mild to moderate infections; 500 mg orally every 6 hours for severe infections.
None Documented
None Documented
Terminal elimination half-life 1.5 hours; prolonged in renal impairment.
0.5–1 hour (normal renal function); prolonged to 2–6 hours in renal impairment.
Renal excretion 80% as unchanged drug, biliary/fecal 10%.
Renal: 60-90% unchanged via tubular secretion and glomerular filtration; minor biliary/fecal: <10%.
Category C
Category C
Penicillin Antibiotic
Penicillin Antibiotic